Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
12 Fevereiro 2024 - 9:30AM
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative
medicine company focused on the development, manufacture, and
commercialization of product solutions for the Advanced Wound Care
and Surgical & Sports Medicine markets, today announced that
management will participate in the BTIG Snowbird MedTech, Digital
Health, Life Science and Diagnostic Tools Conference, which is
being held at the Cliff Lodge in Snowbird, UT from February
13th-14th.
Management will participate in 1x1 meetings on
Wednesday, February 14th. There will be no formal presentation.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading
regenerative medicine company focused on the development,
manufacture and commercialization of solutions for the advanced
wound care and surgical and sports medicine markets. Organogenesis
offers a comprehensive portfolio of innovative regenerative
products to address patient needs across the continuum of care. For
more information, visit www.organogenesis.com.
Investor Inquiries:
ICR Westwicke
Mike Piccinino, CFA
OrganoIR@westwicke.com
Press and Media Inquiries:
Organogenesis
communications@organo.com
Organogenesis (NASDAQ:ORGO)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Organogenesis (NASDAQ:ORGO)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024